{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:52:26Z","timestamp":1792223546977,"version":"4.4.0"},"reference-count":228,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Heart failure (HF) is a complex disease in which cardiomyocyte injury leads to a cascade of inflammatory and fibrosis pathway activation, thereby causing decrease in cardiac function. As a result, several biomolecules are released which can be identified easily in circulating body fluids. The complex biological processes involved in the development and worsening of HF require an early treatment strategy to stop deterioration of cardiac function. Circulating biomarkers provide not only an ideal platform to detect subclinical changes, their clinical application also offers the opportunity to monitor disease treatment. Many of these biomarkers can be quantified with high sensitivity; allowing their clinical application to be evaluated beyond diagnostic purposes as potential tools for HF prognosis. Though the field of biomarkers is dominated by protein molecules, non-coding RNAs (microRNAs, long non-coding RNAs, and circular RNAs) are novel and promising biomarker candidates that encompass several ideal characteristics required in the biomarker field. The application of genetic biomarkers as genetic risk scores in disease prognosis, albeit in its infancy, holds promise to improve disease risk estimation. Despite the multitude of biomarkers that have been available and identified, the majority of novel biomarker candidates are not cardiac-specific, and instead may simply be a readout of systemic inflammation or other pathological processes. Thus, the true value of novel biomarker candidates in HF prognostication remains unclear. In this article, we discuss the current state of application of protein, genetic as well as non-coding RNA biomarkers in HF risk prognosis.<\/jats:p>","DOI":"10.3389\/fcvm.2020.601364","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T05:11:34Z","timestamp":1606108294000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":87,"title":["Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs"],"prefix":"10.3389","volume":"7","author":[{"given":"Apurva","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Haase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"B1","unstructured":"Maryland, MDNhlbiWhat Is Heart Failure?2015"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u22122014 update: a report from the American heart association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1388-9842(02)00034-X","article-title":"Prevalence of chronic heart failure in Southwestern Europe: the EPICA study","volume":"4","author":"Ceia","year":"2002","journal-title":"Eur Heart J"},{"key":"B5","unstructured":"TownsendN\n            WickramasingheK\n            BhatnagarP\n            NicholsMS\n            LealJ\n          LondonBritish Heart FoundationCoronary Heart Disease Statistics (2012 Edition).2012"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ehf2.12005","article-title":"Heart failure: preventing disease and death worldwide","volume":"1","author":"Ponikowski","year":"2014","journal-title":"ESC Heart Fail"},{"key":"B7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bmj.320.7228.167","article-title":"ABC of heart failure Pathophysiology","volume":"320","author":"Jackson","year":"2000","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"B9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0002-9343(02)01048-3","article-title":"Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure","volume":"112","author":"Thomas","year":"2002","journal-title":"Am J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jacc.2007.03.048","article-title":"Echocardiography in heart failure: applications, utility, and new horizons","volume":"50","author":"Kirkpatrick","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1161\/CIRCIMAGING.111.963496","article-title":"Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure","volume":"4","author":"Nagueh","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European Association of cardiovascular imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11897-015-0261-9","article-title":"Role of imaging techniques for diagnosis, prognosis and management of heart failure patients: cardiac magnetic resonance","volume":"12","author":"Gonzalez","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/j.jacc.2009.11.011","article-title":"ACCF\/ACR\/AHA\/NASCI\/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of cardiology foundation task force on expert consensus documents","volume":"55","author":"Hundley","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/eurheartj\/ehp586","article-title":"Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European society of cardiology","volume":"31","author":"Kilner","year":"2010","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the management of heart failure: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart failure society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.hfc.2017.08.002","article-title":"Natriuretic peptides in heart failure: atrial and B-type natriuretic peptides","volume":"14","author":"Maisel","year":"2018","journal-title":"Heart Fail Clin"},{"key":"B19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.peptides.2018.05.012","article-title":"Atrial and brain natriuretic peptides: hormones secreted from the heart","volume":"111","author":"Nakagawa","year":"2019","journal-title":"Peptides"},{"key":"B20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jjcc.2011.01.002","article-title":"Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides","volume":"57","author":"Nishikimi","year":"2011","journal-title":"J Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1139\/y01-031","article-title":"Mechanical load-induced alterations in B-type natriuretic peptide gene expression","volume":"79","author":"Tokola","year":"2001","journal-title":"Canad J Physiol Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am College Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/j.1742-4658.2011.08082.x","article-title":"Natriuretic peptide metabolism, clearance and degradation","volume":"278","author":"Potter","year":"2011","journal-title":"FEBS J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pharmthera.2004.04.004","article-title":"Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance","volume":"102","author":"Abassi","year":"2004","journal-title":"Pharmacol Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.3390\/ijms20112824","article-title":"Clinical applications of natriuretic peptides in heart failure and atrial fibrillation","volume":"20","author":"Baba","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (valsartan heart failure trial)","volume":"52","author":"Masson","year":"2008","journal-title":"J Am College Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","author":"Bettencourt","year":"2004","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1161\/01.CIR.0000143059.68996.A7","article-title":"Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure","volume":"110","author":"Hartmann","year":"2004","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2003.09.044","article-title":"Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure","volume":"43","author":"Logeart","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.hlc.2016.06.1205","article-title":"Prognostic impact of BNP variations in patients admitted for acute decompensated heart failure with in-hospital worsening renal function","volume":"26","author":"Stolfo","year":"2017","journal-title":"Heart Lung Circ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure","volume":"68","author":"Zile","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","article-title":"B-type natriuretic peptide during treatment with sacubitril\/valsartan. the PARADIGM-HF trial","volume":"73","author":"Myhre","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/cc9398","article-title":"Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure","volume":"15","author":"Noveanu","year":"2011","journal-title":"Critical Care"},{"key":"B35","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/eurjhf\/hfs180","article-title":"Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study","volume":"15","author":"Weiner","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.117.029882","article-title":"NT-proBNP (N-terminal pro-B-type natriuretic peptide)-guided therapy in acute decompensated heart failure: PRIMA II randomized controlled trial (Can NT-ProBNP-guided therapy during hospital admission for acute decompensated heart failure reduce mortality and readmissions?)","volume":"137","author":"Stienen","year":"2018","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.RES.62.2.191","article-title":"Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor","volume":"62","author":"Edwards","year":"1988","journal-title":"Circ Res."},{"key":"B38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/324473a0","article-title":"Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney","volume":"324","author":"Marin-Grez","year":"1986","journal-title":"Nature."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1172\/JCI112723","article-title":"Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion","volume":"78","author":"Cody","year":"1986","journal-title":"J Clin Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cca.2014.08.017","article-title":"Atrial natriuretic peptides in plasma","volume":"443","author":"Goetze","year":"2015","journal-title":"Clin Chim Acta."},{"key":"B41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10741-007-9016-3","article-title":"Natriuretic peptides and therapeutic applications","volume":"12","author":"Lee","year":"2007","journal-title":"Heart Fail Rev."},{"key":"B42","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/0024-3205(86)90137-2","article-title":"Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man","volume":"38","author":"Yandle","year":"1986","journal-title":"Life Sci."},{"key":"B43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00870995","article-title":"The pharmacokinetics of \u03b1-human atrial natriuretic polypeptide in healthy subjects","volume":"31","author":"Nakao","year":"1986","journal-title":"Euro J of Clin."},{"key":"B44","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1373\/clinchem.2003.021204","article-title":"Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma","volume":"50","author":"Morgenthaler","year":"2004","journal-title":"Clin Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1016\/j.ijcard.2013.04.164","article-title":"Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure","volume":"168","author":"Seronde","year":"2013","journal-title":"Int J Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2217\/bmm-2019-0083","article-title":"Early NT-proBNP and MR-proANP associated with QoL 1 year after acutely decompensated heart failure: secondary analysis from the MOLITOR trial","volume":"13","author":"Zelenak","year":"2019","journal-title":"Biomark Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/eurjhf\/hfp206","article-title":"The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial","volume":"12","author":"Masson","year":"2010","journal-title":"Euro J Heart Failure."},{"key":"B48","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/heartjnl-2012-302956","article-title":"MR-proANP and MR-proADM for risk stratification of patients with acute chest pain","volume":"99","author":"Tzikas","year":"2013","journal-title":"Heart."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1093\/europace\/euw305","article-title":"Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy","volume":"19","author":"Arrigo","year":"2017","journal-title":"Europace."},{"key":"B50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pcad.2004.07.003","article-title":"Biology of the troponin complex in cardiac myocytes","volume":"47","author":"Parmacek","year":"2004","journal-title":"Prog Cardiovasc Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/eurjhf\/hfs110","article-title":"Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study","volume":"14","author":"Felker","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"B52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/CIRCHEARTFAILURE.113.000450","article-title":"Prognostic effect of high-sensitive troponin t assessment in elderly patients with chronic heart failure","volume":"7","author":"Gravning","year":"2014","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/ejhf.341","article-title":"Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study","volume":"17","author":"Felker","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"B54","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ejhf.988","article-title":"Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study","volume":"20","author":"Welsh","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"B55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ejhf.1359","article-title":"The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes","volume":"21","author":"R\u00f8rth","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.jacc.2016.10.020","article-title":"High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease","volume":"68","author":"Ford","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2014.08.016","article-title":"Troponins in heart failure","volume":"443","author":"Omland","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B58","doi-asserted-by":"publisher","first-page":"636403","DOI":"10.1155\/2011\/636403","article-title":"Myosin binding protein-C: a regulator of actomyosin interaction in striated muscle","volume":"2011","author":"Ackermann","year":"2011","journal-title":"J Biomed Biotechnol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00424-014-1451-0","article-title":"Cardiac myosin binding protein-C: a structurally dynamic regulator of myocardial contractility","volume":"466","author":"Finley","year":"2014","journal-title":"Pfl\u00fcgers Archiv."},{"key":"B60","doi-asserted-by":"publisher","first-page":"16918","DOI":"10.1073\/pnas.0607069103","article-title":"Cardiac myosin binding protein C phosphorylation is cardioprotective","volume":"103","author":"Sadayappan","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e69671","DOI":"10.1371\/journal.pone.0069671","article-title":"Cardiac myosin binding protein-c plays no regulatory role in skeletal muscle structure and function","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS ONE."},{"key":"B62","doi-asserted-by":"publisher","first-page":"9204","DOI":"10.1074\/jbc.M610899200","article-title":"Dissecting the N-terminal myosin binding site of human cardiac myosin-binding protein C. Structure and myosin binding of domain C2","volume":"282","author":"Ababou","year":"2007","journal-title":"J Biol Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/CIRCRESAHA.111.242560","article-title":"A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function","volume":"109","author":"Sadayappan","year":"2011","journal-title":"Circ Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"12318","DOI":"10.1074\/jbc.M808850200","article-title":"The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner","volume":"284","author":"Shaffer","year":"2011","journal-title":"J Biol Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10974-012-9292-y","article-title":"Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro","volume":"33","author":"Govindan","year":"2012","journal-title":"J Muscle Res Cell Motil."},{"key":"B66","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.yjmcc.2011.09.011","article-title":"Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction","volume":"52","author":"Govindan","year":"2012","journal-title":"J Mol Cell Cardiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCRESAHA.113.301225","article-title":"An endogenously produced fragment of cardiac myosin-binding protein C is pathogenic and can lead to heart failure","volume":"113","author":"Razzaque","year":"2013","journal-title":"Circ Res."},{"key":"B68","first-page":"60","article-title":"Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction","volume":"3","author":"Govindan","year":"2013","journal-title":"Am J Cardiovasc Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.yjmcc.2007.05.003","article-title":"Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure","volume":"43","author":"El-Armouche","year":"2007","journal-title":"J Mol Cell Cardiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.yjmcc.2008.05.020","article-title":"Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle","volume":"45","author":"Jacques","year":"2008","journal-title":"J Mol Cell Cardiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/prca.200600891","article-title":"Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies","volume":"1","author":"Zaremba","year":"2007","journal-title":"Proteomics Clin Appl."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.yjmcc.2010.09.007","article-title":"Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle","volume":"9","author":"Copeland","year":"2010","journal-title":"J Mol Cell Cardiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10974-010-9231-8","article-title":"More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease","volume":"31","author":"Hamdani","year":"2010","journal-title":"J Muscle Res Cell Motil."},{"key":"B74","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/CIRCRESAHA.119.314937","article-title":"Comparative analysis of circulating noncoding RNAs versus protein biomarkers in the detection of myocardial injury","volume":"125","author":"Schulte","year":"2019","journal-title":"Circ Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1074\/mcp.M900176-MCP200","article-title":"Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis","volume":"8","author":"Jacquet","year":"2009","journal-title":"Mol Cell Proteomics."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.117.028084","article-title":"Direct comparison of cardiac myosin-binding protein C with cardiac troponins for the early diagnosis of acute myocardial infarction","volume":"136","author":"Kaier","year":"2017","journal-title":"Circulation."},{"key":"B77","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00395-015-0478-5","article-title":"Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury","volume":"110","author":"Baker","year":"2015","journal-title":"Basic Res Cardiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.molmed.2020.02.001","article-title":"Noncoding RNAs versus protein biomarkers in cardiovascular disease","volume":"26","author":"Schulte","year":"2020","journal-title":"Trends Mol Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00246-016-1532-2","article-title":"Diagnostic and prognostic value of plasma levels of cardiac myosin binding protein-C as a novel biomarker in heart failure","volume":"38","author":"El Amrousy","year":"","journal-title":"Pediatric Cardiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1136\/heartjnl-2017-312257","article-title":"Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis","volume":"104","author":"Anand","year":"2018","journal-title":"Heart."},{"key":"B81","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/10408363.2018.1460576","article-title":"Novel heart failure biomarkers: why do we fail to exploit their potential?","volume":"55","author":"Piek","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cca.2017.09.007","article-title":"Heart-type fatty acid-binding protein in cardiovascular disease: a systemic review","volume":"474","author":"Otaki","year":"2017","journal-title":"Clin Chim Acta"},{"key":"B83","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1515\/CCLM.2000.034","article-title":"Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB","volume":"38","author":"Okamoto","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s004249900180","article-title":"Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice","volume":"439","author":"Aartsen","year":"2000","journal-title":"Pflugers Arch"},{"key":"B85","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01270583","article-title":"Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man","volume":"116","author":"Kleine","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1373\/clinchem.2004.047662","article-title":"Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome","volume":"51","author":"Ishii","year":"2005","journal-title":"Clin Chem"},{"key":"B87","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cca.2018.09.004","article-title":"Persistently elevated plasma heart-type fatty acid binding protein concentration is related with poor outcome in acute decompensated heart failure patients","volume":"487","author":"Kazimierczyk","year":"2018","journal-title":"Clin Chim Acta"},{"key":"B88","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1253\/circj.72.109","article-title":"Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure","volume":"72","author":"Niizeki","year":"2008","journal-title":"Circ J"},{"key":"B89","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1253\/circj.69.922","article-title":"Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure","volume":"69","author":"Niizeki","year":"2005","journal-title":"Circ J"},{"key":"B90","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12872-015-0026-0","article-title":"Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I","volume":"15","author":"Hoffmann","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"B91","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jjcc.2012.06.006","article-title":"Ongoing myocardial damage in patients with heart failure and preserved ejection fraction","volume":"60","author":"Kutsuzawa","year":"2012","journal-title":"J Cardiol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"B93","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cellbi.2006.11.036","article-title":"Expression and immunohistochemical localization of galectin-3 in various mouse tissues","volume":"31","author":"Kim","year":"2007","journal-title":"Cell Biol Int"},{"key":"B94","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.1073\/pnas.93.13.6737","article-title":"Expression of galectin-3 modulates T-cell growth and apoptosis","volume":"93","author":"Yang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B95","first-page":"1661","article-title":"Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3","volume":"148","author":"Hsu","year":"1996","journal-title":"Am J Pathol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"247","DOI":"10.14670\/HH-26.247","article-title":"Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues","volume":"26","author":"Sundblad","year":"2011","journal-title":"Histol Histopathol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0167-4889(03)00045-4","article-title":"Galectin-3 expression in macrophages is signaled by Ras\/MAP kinase pathway and up-regulated by modified lipoproteins","volume":"1641","author":"Kim","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"B99","doi-asserted-by":"publisher","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lectin","volume":"296","author":"Liu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cca.2009.09.001","article-title":"The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients","volume":"409","author":"Lin","year":"2009","journal-title":"Clin Chim Acta"},{"key":"B101","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ahj.2012.08.021","article-title":"The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)","volume":"164","author":"Gullestad","year":"2012","journal-title":"Am Heart J"},{"key":"B102","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1161\/CIRCHEARTFAILURE.111.963637","article-title":"Galectin-3 in ambulatory patients with heart failure","volume":"5","author":"Felker","year":"2012","journal-title":"Circulation"},{"key":"B103","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/CIRCHEARTFAILURE.112.000129","article-title":"Prognostic value of changes in galectin-3 levels over time in patients with heart failure","volume":"6","author":"Velde","year":"2013","journal-title":"Circulation"},{"key":"B105","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-\u03b2 superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B106","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0167-4781(97)00122-X","article-title":"PLAB, a novel placental bone morphogenetic protein","volume":"1354","author":"Hromas","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"B107","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0378-1119(97)00485-X","article-title":"Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta","volume":"203","author":"Lawton","year":"1997","journal-title":"Gene"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1093\/emboj\/19.10.2212","article-title":"The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1","volume":"19","author":"Bauskin","year":"2000","journal-title":"EMBO J"},{"key":"B109","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00441-004-0986-3","article-title":"Involvement of growth differentiation factor-15\/macrophage inhibitory cytokine-1 (GDF-15\/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions","volume":"318","author":"Schlittenhardt","year":"2004","journal-title":"Cell Tissue Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/cvr\/cvn082","article-title":"Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery","volume":"79","author":"Berm\u00fadez","year":"2008","journal-title":"Cardiovasc Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1158\/1078-0432.CCR-04-2210","article-title":"The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide","volume":"11","author":"Ferrari","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/01.RES.0000253975.76198.ff","article-title":"Antiangiogenic activity of the MDM2 antagonist nutlin-3","volume":"100","author":"Secchiero","year":"2007","journal-title":"Circ Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1465-9921-12-62","article-title":"GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells","volume":"12","author":"Nickel","year":"2011","journal-title":"Respir Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1210\/en.2008-0952","article-title":"Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes","volume":"150","author":"Ding","year":"2009","journal-title":"Endocrinology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","article-title":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury","volume":"98","author":"Kempf","year":"2006","journal-title":"Circ Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1152\/physiolgenomics.00168.2006","article-title":"Cardiac myocyte gene expression profiling during H2O2-induced apoptosis","volume":"29","author":"Clerk","year":"2007","journal-title":"Physiol Genom"},{"key":"B117","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.107.098046","article-title":"Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program","volume":"51","author":"Frank","year":"2008","journal-title":"Hypertension"},{"key":"B118","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1084\/jem.20100370","article-title":"Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis","volume":"208","author":"De Jager","year":"2011","journal-title":"J Exp Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","article-title":"Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the valsartan heart failure trial","volume":"122","author":"Anand","year":"2010","journal-title":"Circulation"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jacc.2007.04.091","article-title":"Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure","volume":"50","author":"Kempf","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"B122","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1074\/jbc.M111.298703","article-title":"Interleukin 33 as a mechanically responsive cytokine secreted by living cells","volume":"287","author":"Kakkar","year":"2012","journal-title":"J Biol Chem"},{"key":"B123","doi-asserted-by":"publisher","first-page":"3B","DOI":"10.1016\/j.amjcard.2015.01.034","article-title":"The biology of ST2: the international ST2 consensus panel","volume":"115","author":"Pascual-Figal","year":"2015","journal-title":"Am J Cardiol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jchf.2015.07.015","article-title":"Prognostic value of baseline and changes in circulating soluble ST2 levels and the effects of nesiritide in acute decompensated heart failure","volume":"4","author":"Tang","year":"2016","journal-title":"JACC Heart Fail"},{"key":"B125","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12265-016-9713-1","article-title":"Soluble ST2 and risk of arrhythmias, heart failure, or death in patients with mildly symptomatic heart failure: results from MADIT-CRT","volume":"9","author":"Skali","year":"2016","journal-title":"J Cardiovasc Transl Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCHEARTFAILURE.113.001036","article-title":"Prognostic value of soluble ST2 in the valsartan heart failure trial","volume":"7","author":"Anand","year":"2014","journal-title":"Circ Heart Fail"},{"key":"B127","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12938-019-0625-6","article-title":"Potential biomarkers of acute myocardial infarction based on weighted gene co-expression network analysis","volume":"18","author":"Liu","year":"2019","journal-title":"Biomed Eng Online"},{"key":"B128","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","article-title":"Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure","volume":"11","author":"Shah","year":"2020","journal-title":"Nat Commun"},{"key":"B129","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/0002-8703(90)90216-K","article-title":"Parental history is an independent risk factor for coronary artery disease: the Framingham study","volume":"120","author":"Myers","year":"1990","journal-title":"Am Heart J"},{"key":"B130","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa072366","article-title":"Genomewide association analysis of coronary artery disease","volume":"357","author":"Samani","year":"2007","journal-title":"N Engl J Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1126\/science.1142447","article-title":"A common allele on chromosome 9 associated with coronary heart disease","volume":"316","author":"Mcpherson","year":"2007","journal-title":"Science"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1142842","article-title":"A common variant on chromosome 9p21 affects the risk of myocardial infarction","volume":"316","author":"Helgadottir","year":"2007","journal-title":"Science"},{"key":"B133","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Consortium","year":"2007","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","first-page":"12429","DOI":"10.1038\/ncomms12429","article-title":"Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans","volume":"7","author":"Holdt","year":"2016","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/cvr\/cvy084","article-title":"A decade of genome-wide association studies for coronary artery disease: the challenges ahead","volume":"114","author":"Erdmann","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fendo.2020.00354","article-title":"Role of leptin in cardiovascular diseases","volume":"11","author":"Poetsch","year":"2020","journal-title":"Front Endocrinol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2018.06.018","article-title":"Chemerin in human cardiovascular disease","volume":"110","author":"Kaur","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000382","article-title":"Cigarette smoke-induced alterations in blood: a review of research on DNA methylation and gene expression","author":"Silva","year":"2020","journal-title":"Exp Clin Psychopharmacol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/biom8030074","article-title":"Novel DNA methylation sites influence GPR15 expression in relation to smoking","volume":"8","author":"Haase","year":"2018","journal-title":"Biomolecules"},{"key":"B140","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00392-018-1324-1","article-title":"Genetics of coronary artery disease in the light of genome-wide association studies","volume":"107","author":"Schunkert","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/cvr\/cvy083","article-title":"Genome-wide studies of heart failure and endophenotypes: lessons learned and future directions","volume":"114","author":"Van Der Ende","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"R1045","DOI":"10.1152\/ajpregu.00309.2015","article-title":"Cardiac hypertrophy and decreased high-density lipoprotein cholesterol in Lrig3-deficient mice","volume":"310","author":"Hellstr\u00f6m","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/CIRCGENETICS.109.898395","article-title":"Common variants in HSPB7 and FRMD4B associated with advanced heart failure","volume":"3","author":"Cappola","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09899-7.","article-title":"Advances in the role and mechanism of BAG3 in dilated cardiomyopathy","author":"Liu","year":"2019","journal-title":"Heart Fail Rev"},{"key":"B145","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","article-title":"Reevaluating the genetic contribution of monogenic dilated cardiomyopathy","volume":"141","author":"Mazzarotto","year":"2020","journal-title":"Circulation"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e002804","DOI":"10.1161\/CIRCGEN.119.002804","article-title":"Meta-analysis of 26,638 individuals identifies two genetic loci associated with left ventricular ejection fraction","volume":"13","author":"Choquet","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"B147","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/CIRCGENETICS.112.963058","article-title":"Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"B148","doi-asserted-by":"publisher","first-page":"221","DOI":"10.23750\/abm.v90i2.6681","article-title":"Interleukin-10 and transforming growth factor beta1 gene polymorphisms in chronic heart failure","volume":"90","author":"Mahmoudi","year":"2019","journal-title":"Acta Biomed"},{"key":"B149","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail Rev"},{"key":"B150","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.yjmcc.2011.01.014","article-title":"Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities","volume":"50","author":"Schlossarek","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00424-013-1409-7","article-title":"MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction","volume":"466","author":"Behrens-Gawlik","year":"2014","journal-title":"Pflugers Arch"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3389\/fgene.2019.01214","article-title":"Weighted gene co-expression network analysis identifies critical genes in the development of heart failure after acute myocardial infarction","volume":"10","author":"Niu","year":"2019","journal-title":"Front Genet"},{"key":"B153","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1172\/JCI42596","article-title":"Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis","volume":"121","author":"Kreisel","year":"2011","journal-title":"J Clin Invest"},{"key":"B154","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.yjmcc.2010.09.021","article-title":"The PGC-1 cascade as a therapeutic target for heart failure","volume":"51","author":"Schilling","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"B157","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nature12722","article-title":"Dysfunctional nitric oxide signalling increases risk of myocardial infarction","volume":"504","author":"Erdmann","year":"2013","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1056\/NEJMc1700362","article-title":"Genetic risk, lifestyle, and coronary artery disease","volume":"376","author":"Khera","year":"2017","journal-title":"N Engl J Med"},{"key":"B159","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11883-020-00856-6","article-title":"Highlights of studies in cardiovascular disease prevention presented at the 2020 american college of cardiology annual scientific session","volume":"22","author":"Jia","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"B160","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11886-014-0513-4","article-title":"Biomarkers of coronary artery disease: the promise of the transcriptome","volume":"16","author":"Siemelink","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"B161","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12265-016-9673-5","article-title":"Development of a comprehensive sequencing assay for inherited cardiac condition genes","volume":"9","author":"Pua","year":"2016","journal-title":"J Cardiovasc Transl Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/HCO.0000000000000629","article-title":"Polygenic risk scores in coronary artery disease","volume":"34","author":"Rao","year":"2019","journal-title":"Curr Opin Cardiol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/ahg.12302","article-title":"Clinical relevance of genome-wide polygenic score may be less than claimed","volume":"83","author":"Curtis","year":"2019","journal-title":"Ann Hum Genet"},{"key":"B164","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3389\/fgene.2019.00950","article-title":"Epigenetic biomarkers in cardiovascular diseases","volume":"10","author":"Soler-Botija","year":"2019","journal-title":"Front Genet"},{"key":"B165","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1186\/s12864-018-5213-9","article-title":"Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure","volume":"19","author":"Sweet","year":"2018","journal-title":"BMC Genomics"},{"key":"B166","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00059-019-04874-2","article-title":"Biomarkers in primary prevention: meaningful diagnosis based on biomarker scores?","volume":"45","author":"Schulte","year":"2020","journal-title":"Herz"},{"key":"B167","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12929-019-0535-8","article-title":"Sudden Cardiac Death (SCD) \u2013 risk stratification and prediction with molecular biomarkers","volume":"26","author":"Osman","year":"2019","journal-title":"J Biomed Sci"},{"key":"B168","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"B169","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/j.jacc.2016.09.945","article-title":"MicroRNAs in cardiovascular disease","volume":"68","author":"Barwari","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1161\/CIRCRESAHA.110.228676","article-title":"Biogenesis and regulation of cardiovascular microRNAs","volume":"109","author":"Bauersachs","year":"2011","journal-title":"Circ Res"},{"key":"B171","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3978\/j.issn.2223-3652.2014.12.03","article-title":"microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts","volume":"5","author":"Schulte","year":"2015","journal-title":"Cardiovasc Diagn Ther"},{"key":"B172","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4330\/wjc.v7.i12.843","article-title":"Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction","volume":"7","author":"Schulte","year":"2015","journal-title":"World J Cardiol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","article-title":"Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed","volume":"58","author":"Rybak-Wolf","year":"2015","journal-title":"Molecular Cell"},{"key":"B174","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11883-015-0548-z","article-title":"MicroRNA biomarkers for coronary artery disease?","volume":"17","author":"Kaudewitz","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in stress signaling and human disease","volume":"148","author":"Mendell","year":"2012","journal-title":"Cell"},{"key":"B176","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B177","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B178","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat Cell Biol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B180","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/ATVBAHA.112.300139","article-title":"Intercellular transport of microRNAs","volume":"33","author":"Boon","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCRESAHA.116.309303","article-title":"MicroRNA biomarkers and platelet reactivity: the clot thickens","volume":"120","author":"Sunderland","year":"2017","journal-title":"Circ Res"},{"key":"B182","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.critrevonc.2010.11.004","article-title":"Circulating microRNAs: association with disease and potential use as biomarkers","volume":"80","author":"Reid","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","article-title":"Exosomes\u2013vesicular carriers for intercellular communication","volume":"21","author":"Simons","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ Res"},{"key":"B185","doi-asserted-by":"publisher","first-page":"18986","DOI":"10.1073\/pnas.0509535102","article-title":"MicroRNA1 influences cardiac differentiation in drosophila and regulates Notch signaling","volume":"102","author":"Kwon","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B186","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature03817","article-title":"Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis","volume":"436","author":"Zhao","year":"2005","journal-title":"Nature"},{"key":"B187","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.yjmcc.2016.03.015","article-title":"Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction)","volume":"94","author":"Chistiakov","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/eurheartj\/ehs043","article-title":"SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt\/FoxO3A-dependent pathway","volume":"33","author":"Kumarswamy","year":"2012","journal-title":"Eur Heart J"},{"key":"B189","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1128\/MCB.01222-08","article-title":"MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes","volume":"29","author":"Ikeda","year":"2009","journal-title":"Mol Cell Biol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijcard.2015.07.043","article-title":"Micro-RNA and mRNA myocardial tissue expression in biopsy specimen from patients with heart failure","volume":"199","author":"Lai","year":"2015","journal-title":"Int J Cardiol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.18632\/oncotarget.14355","article-title":"Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients","volume":"8","author":"Rigaud","year":"2017","journal-title":"Oncotarget"},{"key":"B192","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijcard.2012.09.108","article-title":"Elevated plasma microRNA-1 predicts heart failure after acute myocardial infarction","volume":"166","author":"Zhang","year":"2013","journal-title":"Int J Cardiol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"e0142237","DOI":"10.1371\/journal.pone.0142237","article-title":"Circulating microRNAs and outcome in patients with acute heart failure","volume":"10","author":"Seronde","year":"2015","journal-title":"PLoS ONE"},{"key":"B194","doi-asserted-by":"publisher","first-page":"e0145930","DOI":"10.1371\/journal.pone.0145930","article-title":"miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease","volume":"10","author":"Schulte","year":"2015","journal-title":"PLoS ONE"},{"key":"B195","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","article-title":"Prospective study on circulating MicroRNAs and risk of myocardial infarction","volume":"60","author":"Zampetaki","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10741-019-09821-1","article-title":"miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure","volume":"25","author":"Cruz","year":"2020","journal-title":"Heart Fail Rev"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.117.032184","article-title":"H19 induces abdominal aortic aneurysm development and progression","volume":"138","author":"Li","year":"2018","journal-title":"Circulation"},{"key":"B198","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/CIRCRESAHA.116.308434","article-title":"Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury","volume":"120","author":"Viereck","year":"2017","journal-title":"Circ Res"},{"key":"B199","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCRESAHA.117.311802","article-title":"Long noncoding RNA discovery in cardiovascular disease: decoding form to function","volume":"122","author":"Sallam","year":"2018","journal-title":"Circ Res"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.114.303915","article-title":"Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure","volume":"114","author":"Kumarswamy","year":"2014","journal-title":"Circ Res"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1101\/gad.1800909","article-title":"Long noncoding RNAs: functional surprises from the RNA world","volume":"23","author":"Wilusz","year":"2009","journal-title":"Genes Dev"},{"key":"B203","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/ajh\/hpx197","article-title":"Noncoding RNAs in cardiovascular disease: pathological relevance and emerging role as biomarkers and therapeutics","volume":"31","author":"Gangwar","year":"2018","journal-title":"Am J Hypertens"},{"key":"B204","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/CIRCRESAHA.116.302521","article-title":"Long noncoding RNAs in cardiovascular diseases","volume":"116","author":"Uchida","year":"2015","journal-title":"Circ Res"},{"key":"B205","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1139\/bcb-2018-0126","article-title":"LncRNA-ANRIL inhibits cell senescence of vascular smooth muscle cells by regulating miR-181a\/Sirt1","volume":"97","author":"Tan","year":"2019","journal-title":"Biochem Cell Biol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1038\/s41467-018-05065-z","article-title":"miR-103 promotes endothelial maladaptation by targeting lncWDR59","volume":"9","author":"Natarelli","year":"2018","journal-title":"Nat Commun"},{"key":"B207","doi-asserted-by":"publisher","first-page":"e19703","DOI":"10.1097\/MD.0000000000019703","article-title":"Association of long-chain non-coding RNA MHRT gene single nucleotide polymorphism with risk and prognosis of chronic heart failure","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"B208","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1093\/eurheartj\/ehaa519","article-title":"Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy","volume":"41","author":"Viereck","year":"2020","journal-title":"Eur Heart J"},{"key":"B209","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12967-016-0926-5","article-title":"Long noncoding RNA dysregulation in ischemic heart failure","volume":"14","author":"Greco","year":"2016","journal-title":"J Transl Med"},{"key":"B210","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1126\/science.143.3601.47","article-title":"Circularity of the replicating form of a single-stranded DNA virus","volume":"143","author":"Chandler","year":"1964","journal-title":"Science"},{"key":"B211","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","article-title":"Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures","volume":"73","author":"Sanger","year":"1976","journal-title":"Proc Natl Acad Sci USA."},{"key":"B212","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/0092-8674(91)90244-S","article-title":"Scrambled exons","volume":"64","author":"Nigro","year":"1991","journal-title":"Cell"},{"key":"B213","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1096\/fasebj.7.1.7678559","article-title":"Mis-splicing yields circular RNA molecules","volume":"7","author":"Cocquerelle","year":"1993","journal-title":"FASEB J"},{"key":"B214","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","article-title":"Detecting and characterizing circular RNAs","volume":"32","author":"Jeck","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B215","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"B216","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","article-title":"Circular intronic long noncoding RNAs","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol Cell"},{"key":"B217","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1093\/nar\/gkl151","article-title":"Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing","volume":"34","author":"Suzuki","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"B218","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/CIRCRESAHA.116.309568","article-title":"RBM20 regulates circular RNA production from the titin gene","volume":"119","author":"Khan","year":"2016","journal-title":"Circ Res"},{"key":"B219","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"B220","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","article-title":"Circ-ZNF609 Is a circular RNA that can be translated and functions in myogenesis","volume":"66","author":"Legnini","year":"2017","journal-title":"Mol Cell"},{"key":"B221","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","article-title":"circRNA biogenesis competes with pre-mRNA splicing","volume":"56","author":"Ashwal-Fluss","year":"2014","journal-title":"Mol Cell"},{"key":"B222","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1242\/dev.128074","article-title":"Circular RNAs: analysis, expression and potential functions","volume":"143","author":"Barrett","year":"2016","journal-title":"Development"},{"key":"B223","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","article-title":"Circular RNA and its mechanisms in disease: from the bench to the clinic","volume":"187","author":"Han","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B224","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/cvr\/cvw250","article-title":"A landscape of circular RNA expression in the human heart","volume":"113","author":"Tan","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/cdd.2017.61","article-title":"Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression","volume":"24","author":"Wang","year":"2017","journal-title":"Cell Death Differ"},{"key":"B226","doi-asserted-by":"publisher","first-page":"e0151753","DOI":"10.1371\/journal.pone.0151753","article-title":"The Circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of mir-7a on its target genes expression","volume":"11","author":"Geng","year":"2016","journal-title":"PLoS ONE"},{"key":"B227","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jacc.2016.06.040","article-title":"Myocardial infarction-associated circular RNA predicting left ventricular dysfunction","volume":"68","author":"Vausort","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijcha.2017.11.001","article-title":"The circular RNA MICRA for risk stratification after myocardial infarction","volume":"17","author":"Salgado-Somoza","year":"2017","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.601364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T05:11:44Z","timestamp":1606108304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.601364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":228,"alternative-id":["10.3389\/fcvm.2020.601364"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2020.601364","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"article-number":"601364"}}